AdvaMed’s Top 10 MedTech Wins in 2022
From MDUFA V and the major investments in semiconductor chip manufacturing in the CHIPS Act, to addressing global supply chain issues and supporting our AdvaMed Accel companies, 2022 was a…
MedTech POV Blog
AdvaMed’s MedTech POV blog features all the latest developments, perspectives, and resources by and for the medical technology community.
Filter By:
Seven Leadership Lessons from The MedTech Conference 2022
The MedTech Conference 2022 featured plenary speakers and panelists who shared enough wisdom to fill books. Read on for leadership lessons from the conference.
Op-ed: New Law Will Help FDA, Medical Technology Industry to Better Serve Patients
In a RealClearHealth op-ed, AdvaMed president and CEO Scott Whitaker outlines how the recently enacted medical device user fee agreement will help the FDA and medical technology innovators.
MDUFA V Enacted, Ushering in Next Era of Medtech for Patients
Congress overwhelmingly approved the fifth Medical Device User Fee Amendment (MDUFA) agreement, helping to ensure new medical technology receives a more efficient FDA review to reach patients sooner if approved.
Listen to AdvaMed's Podcast
Brought to you by AdvaMed, MedTech POV with Scott Whitaker is a podcast that covers the intersection of medtech and policy from every perspective.
“Do it”: Breast Cancer Screening Saves Lives
October is Breast Cancer Awareness Month and a good time to remember the importance of diagnostic screenings in saving lives.
Easing Disparities for Patients via Smart Technology, Equally Smart Policies
CEO and surgeon Dr. Lishan Aklog speaks about the tremendous value of medical technology, the sharp disparities patients face, and the importance of policymaking to ease those disparities.
Updates to AdvaMed Code of Ethics Discussed on Recent Episode of Capital Forum
AdvaMed’s Deputy General Counsel and Senior, VP of Legal, Pat Fogarty, joined Jack Kalavritinos, host of Capital Forum, and Jonathan Turner, Global Head of Compliance, Privacy and Governance, Zoll Medical,…
ResMed CEO Mick Farrell on Leadership, Learning from Experience, and Giving Back
Mick Farrell, CEO of ResMed, joined Scott Whitaker on the MedTech POV podcast to explain what motivates him to serve patients and his community.
Press Contacts
If you have media inquiries, please contact:
Cody Uhing, Director, Communications & Media Relations, 202-316-1423
Managing Your Life Sciences Portfolio: False Claims Act Risk for Private Investors and How AdvaMed Can Help
In recent years, private investors have been subject to increased government enforcement scrutiny under the False Claims Act. Given investors’ vital role in medtech, AdvaMed developed tools and resources to…
Become an AdvaMed Member
Join over 400 medical device manufacturers as a member of one of the most effective trade associations in Washington, D.C.